Change search
ReferencesLink to record
Permanent link

Direct link
Interleukin (IL)-35 is raising our expectations
KTH, School of Biotechnology (BIO).
2010 (English)In: Revista médica de Chile (Impresa), ISSN 0034-9887, E-ISSN 0717-6163, Vol. 138, no 6, 758-766 p.Article, review/survey (Refereed) Published
Abstract [en]

Purpose: To elucidate and discuss the role of IL-35 in immunity to parasitic and bacterial infections as well as in autoimmunity in terms of its anti-inflammatory properties, we highlight significant findings on this novel member of the IL-12 family. Methods: Studies using genetically deficient mice have greatly enhanced our understanding of the biology of IL-35. On the basis of data derived from the analysis of these genetically deficient mice published by NIH, we focus on the key features of this heterodimeric cytokine, especially its relation to the other IL-12 family members, and discuss its potential relevance to the clinical usage. Principal findings: IL-35 is required for the CD4(+)CD25(+) Treg cells-mediated immune regulation, the alleviation of some inflammatory responses, as well as the expansion of CD4(+)CD25(-) Teff cells simultaneously. Moreover, administration or augmentation of IL-35 suppresses some diseases of autoimmune or allergic origin like collagen-induced arthritis or Helicobacter- induced colitis in animal models, demonstrating its potential in therapy of diseases mediated by inflammatory cytokines. However, some questions involving it are still unclear, including the composition of IL-35 receptor, IL-35-related cell signaling pathway, the different expression patterns of IL-35 between human and murine T cells, etc. Conclusion: As our understanding of the IL-35 is rapidly growing and changing, it will bring us more therapeutic strategies towards some intractable immune diseases such as Lupus Erythematosus.

Place, publisher, year, edition, pages
2010. Vol. 138, no 6, 758-766 p.
Keyword [en]
IL-12, IL-35, Treg cells, Teff cells
National Category
Medical Genetics
URN: urn:nbn:se:kth:diva-29454DOI: 10.4067/S0034-98872010000600015ISI: 000280179200015ScopusID: 2-s2.0-77956653839OAI: diva2:396029

QC 20110208. [Las expectativas futuras de la interleukina (IL)-35]

Available from: 2011-02-08 Created: 2011-02-02 Last updated: 2014-08-26Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Zhao, Ning-Wei
By organisation
School of Biotechnology (BIO)
In the same journal
Revista médica de Chile (Impresa)
Medical Genetics

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 44 hits
ReferencesLink to record
Permanent link

Direct link